In MLL-rearranged AML, leukemia stem cells (LSCs) are highly dependent on the purine biosynthesis pathway; CRISPR screens show that purine biosynthetic genes are selectively upregulated in LSCs, and MYC-driven purine metabolism maintains LSC stemness and differentiation arrest [17]. This evidence concerns the gene KMT2A and acute myeloid leukemia.